| MIMS Summary TableMIMS Summary Table | |||
| DRUGS TO AVOID IN G6PD DEFICIENCY | |||
| DEFINITE RISK OF HAEMOLYSISDEFINITE RISK OF HAEMOLYSIS | POSSIBLE RISK OF HAEMOLYSISPOSSIBLE RISK OF HAEMOLYSIS | ||
| Pharmacological ClassPharmacological Class | Drugs*Drugs* | Pharmacological ClassPharmacological Class | Drugs*Drugs* |
| AnthelminticsAnthelmintics | • ß-Naphthol • Niridazole • Stibophen• ß-Naphthol • Niridazole • Stibophen |
AnalgesicsAnalgesics | • Acetylsalicylic acid (Aspirin) • Acetanilide • Paracetamol (Acetaminophen) • Aminophenazone (Aminopyrine) • Dipyrone (Metamizole) • Phenacetin • Phenazone (Antipyrine) • Phenylbutazone • Tiaprofenic acid• Acetylsalicylic acid (Aspirin) • Acetanilide • Paracetamol (Acetaminophen) • Aminophenazone (Aminopyrine) • Dipyrone (Metamizole) • Phenacetin • Phenazone (Antipyrine) • Phenylbutazone • Tiaprofenic acid |
| AntibioticsAntibiotics | • Nitrofurans - Nitrofurantoin - Nitrofurazone • Quinolones - Ciprofloxacin - Moxifloxacin - Nalidixic acid - Norfloxacin - Ofloxacin • Chloramphenicol • Sulfonamides - Co-trimoxazole (Sulfamethoxazole + Trimethoprim) - Sulfacetamide - Sulfadiazine - Sulfadimidine - Sulfamethoxazole - Sulfanilamide - Sulfapyridine - Sulfasalazine (Salazosulfapyridine) - Sulfisoxazole (Sulfafurazole)• Nitrofurans - Nitrofurantoin - Nitrofurazone • Quinolones - Ciprofloxacin - Moxifloxacin - Nalidixic acid - Norfloxacin - Ofloxacin • Chloramphenicol • Sulfonamides - Co-trimoxazole (Sulfamethoxazole + Trimethoprim) - Sulfacetamide - Sulfadiazine - Sulfadimidine - Sulfamethoxazole - Sulfanilamide - Sulfapyridine - Sulfasalazine (Salazosulfapyridine) - Sulfisoxazole (Sulfafurazole) |
||
| AntibioticsAntibiotics | • Furazolidone • Streptomycin • Sulfonamides - Sulfacytine - Sulfaguanidine - Sulfamerazine - Sulfamethoxypyridazole• Furazolidone • Streptomycin • Sulfonamides - Sulfacytine - Sulfaguanidine - Sulfamerazine - Sulfamethoxypyridazole |
||
| AnticonvulsantsAnticonvulsants | • Phenytoin• Phenytoin | ||
| AntidiabeticsAntidiabetics | • Glibenclamide• Glibenclamide | ||
| AntidotesAntidotes | • Dimercaprol (BAL)• Dimercaprol (BAL) | ||
| AntihistaminesAntihistamines | • Antazoline (Antistine) • Diphenhydramine • Tripelennamine• Antazoline (Antistine) • Diphenhydramine • Tripelennamine |
||
| AntimalarialsAntimalarials | • Mepacrine • Pamaquine • Pentaquine • Primaquine• Mepacrine • Pamaquine • Pentaquine • Primaquine |
||
| AntihypertensivesAntihypertensives | • Hydralazine • Methyldopa• Hydralazine • Methyldopa |
||
| Antimethemo- globinaemic AgentsAntimethemo- globinaemic Agents | • Methylene blue• Methylene blue | AntimalarialsAntimalarials | • Chloroquine & derivatives • Proguanil • Pyrimethamine • Quinidine • Quinine• Chloroquine & derivatives • Proguanil • Pyrimethamine • Quinidine • Quinine |
| AntimycobacterialsAntimycobacterials | • Dapsone • Para-aminosalicylic acid • Sulfones - Aldesulfone sodium (Sulfoxone) - Glucosulfone - Thiazosulfone• Dapsone • Para-aminosalicylic acid • Sulfones - Aldesulfone sodium (Sulfoxone) - Glucosulfone - Thiazosulfone |
||
| Antimycobacterials | • Isoniazid | ||
| Antiparkinsonism Agents | • Trihexyphenidyl (Benzhexol) | ||
| Antineoplastic Adjuncts | • Doxorubicin • Rasburicase |
Cardiovascular Drugs | • Dopamine (L-dopa) • Procainamide • Quinidine |
| Genitourinary Analgesics | • Phenazopyridine (Pyridium) | Diagnostic Agent for Cancer Detection |
• Toluidine blue |
| Others | • Acetylphenylhydrazine • Phenylhydrazine |
Gout Preparations | • Colchicine • Probenecid |
| Hormonal Contraceptives | • Mestranol | ||
| Nitrates | • Isobutyl nitrite | ||
| Vitamin K Substance | • Menadiol Na sulfate • Menadione • Menadione Na bisulfite • Phytomenadione |
||
| Vitamins | • Ascorbic acid (Vit C) (rare) | ||
| Others | • Arsine • Berberine (in Coptis chinensis) • Fava beans • Naphthalene (in mothballs) • Para-aminobenzoic acid |
||
| *Nomenclature based on INN (International non-proprietary name) | |||
| Refer to www.g6pd.org for further information. | |||
| Please refer to the Contents page for more Summary Tables. | |||
| Copyright © 2006 MIMS | |||
| ver01032006 | |||
資料來源:財團法人嘉義基督教醫院 http://www.cych.org.tw/pharm/searchdrug.aspx |
|||
| 以上資料只作參考之用,詳情請諮詢醫生 |
|||
2016年4月23日 星期六
G6PD缺乏症避免使用的藥物
2014年2月27日 星期四
香港蘋果日報:止嘔藥Domperidona 兩歲以下不宜服用
香港蘋果日報
A12 | 港聞 | 2015-02-27
A12 | 港聞 | 2015-02-27
止嘔藥Domperidona 兩歲以下不宜服用
【專家之言】
對於澳門五個月大患有蠶豆症男嬰猝死,醫生被指開錯藥,有香港藥劑師指涉事的兩種藥物,其中一種止嘔藥不建議供兩歲以下嬰孩服用,在外國更有警告指長者服用可致死亡;但有心臟科醫生稱兩種藥物均不是蠶豆症禁服藥物。
加國︰長者服用可致命
香港醫院藥劑師學會會長崔俊明指,止嘔藥Domperidona可治療腸胃不適及作嘔作悶。今年一月,加拿大衞生當局發出警告,指六十歲以上長者服用此藥,可引致心律不齊、心臟停頓及突然死亡等風險。而本港醫生使用此止嘔藥,一般建議兩歲以上小孩才可服用。但崔表示,醫生有權為兩歲以下嬰孩處方此藥作「非適應症治療」,但必須同時向病童父母表明風險。
心臟科醫生何鴻光稱,蠶豆症病人一旦服錯藥致病發,會出現溶血症致貧血,會致全身黃疸、小便轉色等病徵,即使有致命風險,亦非半日內會發生,「多幾日先會有事」。對於蠶豆症,醫學界有一禁用藥物列表,但涉事兩種藥物均非列表內,其中止嘔藥更屬常用藥物,會按醫生臨床判斷是否處方予病童。
■記者龔蕙芝
資料來源:G6PD 缺乏症/蠶豆症資訊站
https://www.facebook.com/G6PD-%E7%BC%BA%E4%B9%8F%E7%97%87%E8%A0%B6%E8%B1%86%E7%97%87%E8%B3%87%E8%A8%8A%E7%AB%99-215564885253417/?fref=ts
以上資料只作參考之用,詳情請諮詢醫生
https://www.facebook.com/G6PD-%E7%BC%BA%E4%B9%8F%E7%97%87%E8%A0%B6%E8%B1%86%E7%97%87%E8%B3%87%E8%A8%8A%E7%AB%99-215564885253417/?fref=ts
以上資料只作參考之用,詳情請諮詢醫生
訂閱:
文章 (Atom)